Zolpidém

Zolpidém is a medication commonly prescribed for the short-term treatment of insomnia. It belongs to a class of drugs called sedative-hypnotics, which work by enhancing the effect of a neurotransmitter in the brain called GABA. This neurotransmitter helps to slow down brain activity, leading to sedation and sleep. Zolpidém is available in various forms, including immediate-release tablets, extended-release tablets, and sublingual tablets, each designed to address different sleep onset and maintenance issues.

The medication is typically taken just before bedtime and is intended for occasional use, generally for no more than a few weeks. Prolonged use can lead to tolerance, dependence, and withdrawal symptoms. Common side effects can include drowsiness, dizziness, and fatigue. More serious side effects, though less common, may involve complex sleep behaviors such as sleepwalking, sleep-driving, or sleep-eating, often without memory of the event.

Zolpidém is a controlled substance in many countries due to its potential for misuse and dependence. It is important to use zolpidém exactly as prescribed by a healthcare professional and to avoid activities requiring full alertness, such as driving, after taking the medication. Individuals with a history of substance abuse, respiratory problems, or certain liver conditions may not be suitable candidates for zolpidém. Consulting a doctor is essential to determine if zolpidém is the appropriate treatment for insomnia and to discuss potential risks and benefits.